Filing Flows › Outset Medical (OM) › Q3 2026
Outset Medical (OM) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
Outset Medical (OM) reported revenue of $33.6M for the third quarter 2026 (Q3 2026), +14% from a year earlier and +6% from the quarter before. Operating margin was -36.5%, net loss $14.7M (43.7% of revenue).
Outset Medical, Q3 2026: revenue $33.6M (+14% year over year), operating margin -36.5%, net loss $14.7M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.6M | +6% | +14% |
| Operating profit | −$12.3M | — | — |
| Net earnings | −$14.7M | — | — |
| Operating cash flow | −$10.4M | — | — |
What changed
Revenue was $33.6M in Q3 2026, up 14% year over year and up 6% from the previous quarter. Consumables Product was the largest line at 39% of revenue. Consoles Product added $2.1M year over year (up 26%), 51% of the total change.
Gross margin was 40.7%, up 1.3 points from Q3 2025. Operating costs exceeded revenue by $12.3M, an operating margin of -36.5%. Operating expenses fell 5% while revenue rose 14%. The quarter ended with a net loss of $14.7M, narrower than the previous quarter's $18.0M loss.
Operating cash flow was −$10.4M. Non-cash charges added back $666K of depreciation and amortization and $1.7M of share-based compensation. Working capital and other items added $2.0M. Capital expenditures of $109K exceeded it, leaving free cash flow of −$10.5M.
Questions
What was Outset Medical's revenue in the third quarter 2026?
Outset Medical (OM) reported revenue of $33.6M for the third quarter 2026 (Q3 2026), +14% from a year earlier and +6% from the quarter before.
Was Outset Medical profitable in the third quarter 2026?
Operating loss was $12.3M (-36.5% of revenue) and net loss $14.7M.
Source: Outset Medical 10-Q on SEC EDGAR.